ATA151687A - Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen) - Google Patents

Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)

Info

Publication number
ATA151687A
ATA151687A AT0151687A AT151687A ATA151687A AT A151687 A ATA151687 A AT A151687A AT 0151687 A AT0151687 A AT 0151687A AT 151687 A AT151687 A AT 151687A AT A151687 A ATA151687 A AT A151687A
Authority
AT
Austria
Prior art keywords
nitrofurantoin
hydrates
complexes
salts
producing
Prior art date
Application number
AT0151687A
Other languages
English (en)
Other versions
AT398166B (de
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of ATA151687A publication Critical patent/ATA151687A/de
Application granted granted Critical
Publication of AT398166B publication Critical patent/AT398166B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0151687A 1986-06-16 1987-06-15 Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen) AT398166B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,943 US4772473A (en) 1986-06-16 1986-06-16 Nitrofurantoin dosage form

Publications (2)

Publication Number Publication Date
ATA151687A true ATA151687A (de) 1994-02-15
AT398166B AT398166B (de) 1994-10-25

Family

ID=25364916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0151687A AT398166B (de) 1986-06-16 1987-06-15 Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)

Country Status (13)

Country Link
US (1) US4772473A (de)
EP (1) EP0250023B1 (de)
JP (1) JP2509226B2 (de)
AT (1) AT398166B (de)
AU (1) AU592731B2 (de)
CA (1) CA1288050C (de)
DE (1) DE3772113D1 (de)
DK (1) DK173432B1 (de)
IE (1) IE60661B1 (de)
IL (1) IL82807A (de)
NZ (1) NZ220695A (de)
PH (1) PH22843A (de)
ZA (1) ZA874316B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
US5360402A (en) * 1990-01-10 1994-11-01 Rochester Medical Corporation Hand-actuated retention catheter
US5971954A (en) * 1990-01-10 1999-10-26 Rochester Medical Corporation Method of making catheter
US6626888B1 (en) 1990-01-10 2003-09-30 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
US5269770A (en) * 1990-01-10 1993-12-14 Rochester Medical Corporation Microcidal agent releasing catheter with balloon
US5261896A (en) * 1990-01-10 1993-11-16 Rochester Medical Corporation Sustained release bactericidal cannula
US5670111A (en) 1990-01-10 1997-09-23 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
KR20010099975A (ko) * 1998-12-28 2001-11-09 우에하라 아끼라 외용제
EP1244428A1 (de) * 1999-12-06 2002-10-02 Edward Mendell Co., Inc. Pharmazeutisches supersprengmittel
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
EP1635794A2 (de) * 2002-08-23 2006-03-22 Ranbaxy Laboratories, Ltd. Nitrofurantoin-dosierform mit kontrollierter freisetzung
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
NZ553587A (en) * 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmacutically acceptable salt thereof
EA201001086A1 (ru) 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
US8603200B2 (en) * 2009-06-22 2013-12-10 Afton Chemical Corporation Compositions comprising combustion improvers and methods of use thereof
CN102000041A (zh) * 2010-11-19 2011-04-06 合肥合源药业有限公司 含有速释和缓释两种成分的呋喃坦啶胶囊及其制备方法
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
KR102462510B1 (ko) 2014-08-26 2022-11-01 씨. 알. 바드, 인크. 요로 카테터
JP7350722B2 (ja) 2017-09-19 2023-09-26 シー・アール・バード・インコーポレーテッド 尿カテーテルブリッジ装置、そのシステムおよび方法
US12589218B2 (en) 2020-08-03 2026-03-31 C. R. Bard, Inc. Intermittent-catheter assembly and methods thereof
CN116322871A (zh) 2020-09-11 2023-06-23 C·R·巴德股份有限公司 间歇导管组件及其方法
EP4285895A1 (de) * 2022-06-03 2023-12-06 Adalvo Limited Orale dosierungsform von nitrofurantoin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
PH22843A (en) 1989-01-19
ZA874316B (en) 1988-08-31
IL82807A0 (en) 1987-12-20
CA1288050C (en) 1991-08-27
AU592731B2 (en) 1990-01-18
JPS63258420A (ja) 1988-10-25
NZ220695A (en) 1990-08-28
DK306487D0 (da) 1987-06-16
IE871585L (en) 1987-12-16
AU7421187A (en) 1987-12-17
JP2509226B2 (ja) 1996-06-19
AT398166B (de) 1994-10-25
IL82807A (en) 1991-12-12
IE60661B1 (en) 1994-08-10
US4772473A (en) 1988-09-20
EP0250023B1 (de) 1991-08-14
DE3772113D1 (de) 1991-09-19
EP0250023A1 (de) 1987-12-23
DK173432B1 (da) 2000-10-23
DK306487A (da) 1987-12-17

Similar Documents

Publication Publication Date Title
ATA151587A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
FI881978L (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI871914L (fi) Menetelmä oraalisen farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan
FI871913L (fi) Menetelmä oraalisen, farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan
FI870155L (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
NO861331L (no) Fremgangsmaate for fremstilling av et hyaluronsyresalt.
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
FI880163L (fi) Menetelmä lääkeaineena käytettävän liuoksen valmistamiseksi
ATA170086A (de) Verfahren zur herstellung einer festen haltbaren darreichungsform
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
NO883054L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
FI873106L (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
DE3769662D1 (de) Verfahren zur herstellung eines stabilen nicorandilpraeparats.
NO870866L (no) FremgangsmŸte for fremstilling av et terapeutisk kombinasjonspreparat.
DE68909799D1 (de) Verfahren zur Herstellung von Bisphenol A.
DE3850230D1 (de) Verfahren zur Herstellung von Alkylthioethylaminsalzen.
ATA81985A (de) Verfahren zur herstellung einer zur oralen verabreichung von etoposid bestimmten weichgelantinekapsel
FI873800A7 (fi) Nor-kolaanihappojohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö sekä niitä sisältävät farmaseuttiset seokset.
ATA279787A (de) Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion
ATA92982A (de) Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
AT389227B (de) Verfahren zur herstellung einer chelatkomplexe von l-3,4-dihydroxyphenyl-alpha-methyl-alaninenthaltenden pharmazeutischen loesung

Legal Events

Date Code Title Description
EFA Change in the company name
UEP Publication of translation of european patent specification
ELA Expired due to lapse of time